CD44 and prostate carcinoma: Consistently, there is evidence showing that miR-34a antagomirs promote metastasis in CD44- prostate cancer cells, suggesting that downregulation of miR-34a in cancer stem cells contributes to metastasis via regulation of CD44 expression [49].